Use of patient and disease characteristics as predictive indicators of rituximab infusion related reactions (R-IRR) in adult malignant hematology patients at an academic medical center
ConclusionActual body weight and bone marrow involvement may be utilized as potential predictive indicators of R-IRR. Further research is needed to validate these indicators and determine appropriate utilization in practice.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Academia | Cancer & Oncology | Chemotherapy | Hematology | Leukemia | Lymphoma | Myeloma | Pregnancy | Rituxan | Study